BANK OF AMERICA CORP /DE/
BankPosition in NTLA — Intellia Therapeutics, Inc.
CIK 70858
CHARLOTTE, NC
Position in NTLA
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$17,713,431
+$6,544,456 QoQ
Shares Held
1,381,703
+11.2% QoQ
Ownership
0.989%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 82%
Shared 0%
None 18%
Common Shares in NTLA Over Time
Shares Held
Position Value (USD)
Derivatives in NTLA
reported options exposure · as of Jun 30, 2022CallValue
$1,552,800
CallShares
30,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,548,750,242 across 347 Biotechnology names. NTLA ranks #80 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,834 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,177 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,986 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,936 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in NTLA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $17,713,431 | 1,381,703 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $11,168,975 | 1,242,378 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $10,457,429 | 605,526 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $4,025,406 | 429,148 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $6,723,093 | 945,583 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $7,458,853 | 639,696 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $14,717,722 | 716,191 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $14,496,284 | 647,734 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $17,232,894 | 626,423 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $11,579,641 | 379,785 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $13,086,692 | 413,874 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $16,748,017 | 410,692 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $49,982,533 | 1,341,093 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $23,996,817 | 687,785 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $16,836,737 | 300,871 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $19,339,345 | 373,635 | Shares | Defined | 2022-08-12 | |
| 2022-06-30 | $1,552,800 | 30,000 | Call | Defined | 2022-08-12 | |
| 2022-03-31 | $24,495,818 | 337,083 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $34,348,125 | 290,495 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $40,160,214 | 299,368 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $45,700,714 | 282,260 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $27,305,477 | 340,234 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $6,124,186 | 112,577 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $1,170,950 | 58,901 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $524,995 | 24,976 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $437,221 | 35,750 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||